Evidence map›Paper›PMID 33130958›Full record

ArticleThe protein journal2020

Integrated In Silico-In Vitro Identification and Optimization of Bone Morphogenic Protein-2 Armpit Epitope as Its Antagonist Binding Site.

Yanping Wu, Guanghong Jia, Haiyan Chi, Zhaode Jiao, Yinghua Sun

Abstract read
PubMed Publisher
In one paragraph

Article in The protein journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 6 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Yanping WuDepartment of Joint and Traumatic Orthopedics, Yidu Central Hospital Affiliated to Weifang Medical University, Weifang, 262500, China.
Guanghong JiaDepartment of Pediatrics, Yidu Central Hospital Affiliated to Weifang Medical University, Weifang, 262500, China.
Haiyan ChiDepartment of Pediatrics, Yidu Central Hospital Affiliated to Weifang Medical University, Weifang, 262500, China.
Zhaode JiaoDepartment of Joint and Traumatic Orthopedics, Yidu Central Hospital Affiliated to Weifang Medical University, Weifang, 262500, China.
Yinghua SunDepartment of Joint and Traumatic Orthopedics, Yidu Central Hospital Affiliated to Weifang Medical University, Weifang, 262500, China. yinghuasun@tom.com.ORCID 0000-0002-8038-2197
Weifang Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bone morphogenic protein-2 (BMP-2) is the most documented member of BMP family and plays a crucial role in bone formation and growth. In this study, we systematically analyze and compare the complex crystal structures and interaction properties of BMP-2 with its cognate receptors BMPR-I/BMPR-II and with its natural antagonist crossveinless-2 (CV-2) using an integrated in silico-in vitro strategy. It is found that the antagonist-binding site is not fully overlapped with the two receptor-binding sites on BMP-2 surface; the antagonist can competitively disrupt BMP-2-BMPR-II interaction using a blocking-out-of-site manner, but has no substantial influence on BMP-2-BMPR-I interaction. Here, the antagonist-binding site is assigned as a new functional epitope armpit to differ from the traditional conformational epitope wrist and linear epitope knuckle at receptor-binding sites. Structural analysis reveals that the armpit comprises three sequentially discontinuous, structurally vicinal peptide segments, separately corresponding to a loop region and two β-strands crawling on the protein surface. The three segments cannot work independently when splitting from the protein context, but can restore binding capability to CV-2 if they are connected to a single peptide. A systematic combination of different-length polyglycine linkers between these segments obtains a series of designed single peptides, from which several peptides that can potently interact with the armpit-recognition site of CV-2 with high affinity and specificity are identified using energetic analysis and fluorescence assay; they are expected to target BMP-2-CV-2 interaction in a self-inhibitory manner.

Indexed as

Computer SimulationBinding SitesBone Morphogenetic Protein 2Bone Morphogenetic Protein Receptors, Type IBone Morphogenetic Protein Receptors, Type IICarrier ProteinsEpitopesHumansBMP2 protein, humanBMPER protein, humanBMPR2 protein, humanBone Morphogenetic Protein 2Bone Morphogenetic Protein Receptors, Type IBone Morphogenetic Protein Receptors, Type IICarrier ProteinsEpitopesAntagonistArmpit epitopeBone morphogenic protein-2Molecular recognitionPeptide

Identifiers

PMID33130958
OpenAlexW3096215034

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.